Elafibranor, an agonist of the peroxisome proliferator-activated receptor- and -, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
The observed reduction in both systolic and diastolic left ventricular diameters, along with improved left ventricular ejection fraction in the LC supplemented group, suggests a potential contribution of CABG to reverse remodeling
The future of antioxidant therapy likely lies in this integrative approachcombining targeted molecular hydrogen delivery through hydrogen-rich water with strategies to support endogenous antioxidant systems like glutathione reductase
Winners must claim prize in person within 5 days of announcement
So, Im thinking, well, when you forget stuff, a name or something, Oh man, that must be my amyloid and tau in my brain, whatever. So, this breakthrough, the biggest breakthrough in neuroscience in decades, is this p-tau217
It became the leader because the operating model was breaking